SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-006841
Filing Date
2019-05-15
Accepted
2019-05-15 17:12:59
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20190331.htm   iXBRL 10-Q 861296
2 EXHIBIT-10.1 cpixq12019-exhibit101.htm EX-10.1 18777
3 EXHIBIT-10.2 cpixq12019-exhibit102.htm EX-10.2 31272
4 EXHIBIT-31.1 cpixq12019-exhibit311.htm EX-31.1 16130
5 EXHIBIT-31.2 cpixq12019-exhibit312.htm EX-31.2 16139
6 EXHIBIT-32.1 cpixq12019-exhibit321.htm EX-32.1 9268
  Complete submission text file 0001628280-19-006841.txt   3923776

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20190331.xsd EX-101.SCH 29949
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20190331_cal.xml EX-101.CAL 71012
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20190331_def.xml EX-101.DEF 96860
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20190331_lab.xml EX-101.LAB 349989
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20190331_pre.xml EX-101.PRE 225382
12 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20190331_htm.xml XML 567460
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 19829574
SIC: 2834 Pharmaceutical Preparations